These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 28197411)

  • 1. Toxicity Studies of Ethyl Maltol and Iron Complexes in Mice.
    Li Z; Lu J; Wu C; Pang Q; Zhu Z; Nan R; Du R; Chen J
    Biomed Res Int; 2017; 2017():2640619. PubMed ID: 28197411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the pyrones, maltol and ethyl maltol, on iron absorption from the rat small intestine.
    Barrand MA; Callingham BA; Hider RC
    J Pharm Pharmacol; 1987 Mar; 39(3):203-11. PubMed ID: 2883285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absorption of iron from ferric hydroxypyranone complexes.
    Maxton DG; Thompson RP; Hider RC
    Br J Nutr; 1994 Feb; 71(2):203-7. PubMed ID: 8142332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ferric maltol therapy for iron deficiency anaemia in patients with inflammatory bowel disease: long-term extension data from a Phase 3 study.
    Schmidt C; Ahmad T; Tulassay Z; Baumgart DC; Bokemeyer B; Howaldt S; Stallmach A; Büning C;
    Aliment Pharmacol Ther; 2016 Aug; 44(3):259-70. PubMed ID: 27237709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of iron(III) uptake by isolated fragments of rat small intestine in the presence of the hydroxypyrones, maltol and ethyl maltol.
    Levey JA; Barrand MA; Callingham BA; Hider RC
    Biochem Pharmacol; 1988 May; 37(10):2051-7. PubMed ID: 3377810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maltol/iron-mediated apoptosis in HL60 cells: participation of reactive oxygen species.
    Murakami K; Ishida K; Watakabe K; Tsubouchi R; Naruse M; Yoshino M
    Toxicol Lett; 2006 Feb; 161(2):102-7. PubMed ID: 16143472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absorption of low and therapeutic doses of ferric maltol, a novel ferric iron compound, in iron deficient subjects using a single dose iron absorption test.
    Kelsey SM; Hider RC; Bloor JR; Blake DR; Gutteridge CN; Newland AC
    J Clin Pharm Ther; 1991 Apr; 16(2):117-22. PubMed ID: 1856249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized Open-Label Phase 1 Study of the Pharmacokinetics of Ferric Maltol in Inflammatory Bowel Disease Patients with Iron Deficiency.
    Bokemeyer B; Krummenerl A; Maaser C; Howaldt S; Mroß M; Mallard N
    Eur J Drug Metab Pharmacokinet; 2017 Apr; 42(2):229-238. PubMed ID: 27101422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The importance of reductive mechanisms for intestinal uptake of iron from ferric maltol and ferric nitrilotriacetic acid (NTA).
    Barrand MA; Hider RC; Callingham BA
    J Pharm Pharmacol; 1990 Apr; 42(4):279-82. PubMed ID: 1974298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissociation of a ferric maltol complex and its subsequent metabolism during absorption across the small intestine of the rat.
    Barrand MA; Callingham BA; Dobbin P; Hider RC
    Br J Pharmacol; 1991 Mar; 102(3):723-9. PubMed ID: 1364845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Effectiveness of Oral Ferric Maltol vs Intravenous Ferric Carboxymaltose for the Treatment of Iron-Deficiency Anemia in Patients With Inflammatory Bowel Disease: A Randomized Controlled Noninferiority Trial.
    Howaldt S; Domènech E; Martinez N; Schmidt C; Bokemeyer B
    Inflamm Bowel Dis; 2022 Mar; 28(3):373-384. PubMed ID: 33988236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for regulatory control of iron uptake from ferric maltol across the small intestine of the rat.
    Barrand MA; Callingham BA
    Br J Pharmacol; 1991 Feb; 102(2):408-14. PubMed ID: 2015422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood glucose lowering and toxicological effects of zinc (II) complexes with maltol, threonine, and picolinic acid.
    Kojima Y; Yoshikawa Y; Ueda E; Kondo M; Takahashi S; Matsukura T; Sakurai H; Hiroi T; Imaoka S; Funae Y
    Res Commun Mol Pathol Pharmacol; 2002; 112(1-4):91-104. PubMed ID: 15080500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ferric maltol is effective in correcting iron deficiency anemia in patients with inflammatory bowel disease: results from a phase-3 clinical trial program.
    Gasche C; Ahmad T; Tulassay Z; Baumgart DC; Bokemeyer B; Büning C; Howaldt S; Stallmach A;
    Inflamm Bowel Dis; 2015 Mar; 21(3):579-88. PubMed ID: 25545376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interventions for treating iron deficiency anaemia in inflammatory bowel disease.
    Gordon M; Sinopoulou V; Iheozor-Ejiofor Z; Iqbal T; Allen P; Hoque S; Engineer J; Akobeng AK
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD013529. PubMed ID: 33471939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ferric Maltol: A New Oral Iron Formulation for the Treatment of Iron Deficiency in Adults.
    Khoury A; Pagan KA; Farland MZ
    Ann Pharmacother; 2021 Feb; 55(2):222-229. PubMed ID: 32633548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A long-term intravenous model of aluminum maltol toxicity in rabbits: tissue distribution, hepatic, renal, and neuronal cytoskeletal changes associated with systemic exposure.
    Bertholf RL; Herman MM; Savory J; Carpenter RM; Sturgill BC; Katsetos CD; Vandenberg SR; Wills MR
    Toxicol Appl Pharmacol; 1989 Mar; 98(1):58-74. PubMed ID: 2648649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on passiflora incarnata dry extract. I. Isolation of maltol and pharmacological action of maltol and ethyl maltol.
    Aoyagi N; Kimura R; Murata T
    Chem Pharm Bull (Tokyo); 1974 May; 22(5):1008-13. PubMed ID: 4421168
    [No Abstract]   [Full Text] [Related]  

  • 19. The investigation of the binding behavior between ethyl maltol and human serum albumin by multi-spectroscopic methods and molecular docking.
    Yue Y; Liu J; Yao M; Yao X; Fan J; Ji H
    Spectrochim Acta A Mol Biomol Spectrosc; 2012 Oct; 96():316-23. PubMed ID: 22705675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral Ferric Maltol for the Treatment of Iron-Deficiency Anemia in Patients With CKD: A Randomized Trial and Open-Label Extension.
    Pergola PE; Kopyt NP
    Am J Kidney Dis; 2021 Dec; 78(6):846-856.e1. PubMed ID: 34029682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.